Magenta Therapeutics Launches Proposed Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- AMD shares fall amid AI chip sector selloff
- Alphabet shares drop ahead of earnings next week
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Magenta Therapeutics (MGTA) Book Building for May 2 Trading
April 29, 2019 5:30 PM EDTMagenta Therapeutics (NASDAQ: MGTA) 4.25 million share offering is a 2-day book build for an expected May 2nd trade date, according to Bloomberg.
J.P. Morgan, Goldman Sachs & Co. LLC and Cowen are acting as joint book running managers for the offering.... More



